Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 5737 | 112 | 0.2848 | 0.2652 | 0.0195 | 0.0225 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 8744 | 163 | 0.4345 | 0.4180 | 0.0186 | 0.0173 |
A-375 | Vemurafenib | JNK-IN-8 | 3.160 | 0.000 | uM | 72 | hr | 1 | 2723 | 183 | 0.1598 | 0.1658 | 0.0672 | 0.0732 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 8666 | 164 | 0.4305 | 0.4180 | 0.0189 | 0.0173 |
A-375 | Vemurafenib | JNK-IN-8 | 3.160 | 0.000 | uM | 72 | hr | 3 | 2847 | 209 | 0.1659 | 0.1658 | 0.0734 | 0.0732 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 20940 | 1098 | 1.0048 | 1.0000 | 0.0524 | 0.0504 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 3598 | 270 | 0.1685 | 0.1621 | 0.0750 | 0.0672 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 22233 | 990 | 1.0180 | 1.0000 | 0.0445 | 0.0468 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 13441 | 248 | 0.6323 | 0.4565 | 0.0185 | 0.0200 |
A-375 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 5034 | 110 | 0.2493 | 0.2652 | 0.0219 | 0.0225 |
A-375 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 3774 | 124 | 0.1848 | 0.1953 | 0.0329 | 0.0349 |
A-375 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 3957 | 137 | 0.1934 | 0.1953 | 0.0346 | 0.0349 |
A-375 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 4259 | 158 | 0.2077 | 0.1953 | 0.0371 | 0.0349 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 19971 | 929 | 0.9642 | 1.0000 | 0.0465 | 0.0504 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 0.000 | uM | 72 | hr | 1 | 17029 | 767 | 1.0229 | 1.0000 | 0.0450 | 0.0476 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 7654 | 162 | 0.3590 | 0.4565 | 0.0212 | 0.0200 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 8056 | 164 | 0.3782 | 0.4565 | 0.0204 | 0.0200 |
A-375 | Vemurafenib | Defactinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 5186 | 150 | 0.2413 | 0.2413 | 0.0289 | 0.0233 |
A-375 | Vemurafenib | Defactinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 5017 | 89 | 0.2362 | 0.2413 | 0.0177 | 0.0233 |
A-375 | Vemurafenib | Defactinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 5264 | 123 | 0.2464 | 0.2413 | 0.0234 | 0.0233 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 3 | 7190 | 141 | 0.4434 | 0.4477 | 0.0196 | 0.0178 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 21481 | 1121 | 1.0310 | 1.0000 | 0.0522 | 0.0504 |
A-375 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 3477 | 209 | 0.1655 | 0.1621 | 0.0601 | 0.0672 |
A-375 | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 2 | 7861 | 159 | 0.4190 | 0.4213 | 0.0202 | 0.0200 |
A-375 | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 1 | 8355 | 177 | 0.4449 | 0.4213 | 0.0212 | 0.0200 |